Autolomous and Cellular Origins today announce end-to-end integration of their respective platforms, bringing full automation ...

Cellular and gene therapies have become established treatment options for hematological diseases, including rare and aggressive neoplasms. The clinical ...

Partnership pairs Applied StemCell's induced pluripotent stem cell technology with RoosterBio's engineered media, reagents, ...

Helixmith, led by CEO Jang Song-seon, is moving to secure a next-generation "smart manufacturing process" for cell and gene therapies (CGT) by integra ...

CITY OF INDUSTRY, CA, UNITED STATES, June 29, 2026 /EINPresswire.com/ -- During formulation trials in a pharmaceutical ...

Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...

For those who wonder what the support window is for Apple products, the company now has an answer: it’s quietly ended support ...

The Universitat Autònoma de Barcelona (UAB) and the Institute of Microelectronics of Barcelona (IMB-CNM-CSIC) have developed a new generation of wireless piezoelectric microdevices capable of ...

MIT scientists have discovered that part of these microorganisms' energy efficiency depends on invisible signals embedded ...

TG-MVATM uses a scalable cell line manufacturing process intended to strengthen and diversify global mpox and smallpox vaccine supplyTG-MVATM ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced Ryoncil ® (remestemcel-L-rknd) net revenue of US$36 million for the ...